Integrating Chinese medicine in the management of atrial fibrillation: a retrospective EMR-based study

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2024000224

Enrollment

Unknown

Registered

2024-08-13

Start date

2024-08-20

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Not applicable.:Not applicable.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) patients aged over 18 years (2) discharged from the general or any of the three other branches of Guangdong Provincial Hospital of Chinese Medicine between January 2013 and December 2022 (3) diagnosed with any type of atrial fibrillation

Exclusion criteria

Exclusion criteria: Not applicable.

Design outcomes

Primary

Measure	Time frame
major adverse cardiovascular events;	—

Secondary

Measure	Time frame
Pulmonary function report;Imaging report;Chinese medicine and western medicine therapies;Neuroendocrine markers;Markers of myocardial injury;Biochemical tests;Heart rhythm, heart rate and methods and frequency to monitor heart rhythm and heart rate;Sleep breathing monitoring report;Thrombus markers;Inflammatory markers;	—

Countries

China

Contacts

Public ContactYiyi Cai

Guangdong Provincial Hospital of Chinese Medicine

caiyiyi@gzucm.edu.cn+86-020-81887233-34629

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026